Clinicopathological Characteristics, Treatment and Prognosis in Duodenal Adenocarcinoma with Liver Metastasis: A SEER-Based Study

References

• Jiang S, Zhao R, Li Y, et al. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: a retrospective study in China and the SEER database. Sci Rep. 2018;8(1):7940. doi:10.1038/s41598-018-26145-6
   PubMedGoogle Scholar
• Li D, Si X, Wan T, Zhou Y. Outcomes of surgical resection for primary duodenal adenocarcinoma: a systematic review. Asian J Surg. 2019;42(1):46–52.
   PubMed Web of Science ®Google Scholar
• Platoff RM, Kellish AS, Hakim A, et al. Simple versus radical resection for duodenal adenocarcinoma: a propensity score matched analysis of national cancer database. Am Surg. 2021;87(2):266–275. doi:10.1177/0003134820951432
   PubMed Web of Science ®Google Scholar
• Kato T, Ono Y, Oba A, et al. Comparison of the clinical efficacy of a new prognostic stratification for duodenal adenocarcinoma with that of TNM staging: the importance of T status with regard to the prognosis. Eur J Surg Oncol. 2023;49(1):122–128. doi:10.1016/j.ejso.2022.08.005
   PubMed Web of Science ®Google Scholar
• Topal U, Arıkan TB, Sozuer E, Akyıldız HY, Gok M. Surgical treatment and outcome for primary duodenal adenocarcinoma. Single Center Experience Ann Ital Chir. 2021;92:41–47.
   PubMed Web of Science ®Google Scholar
• López-Domínguez J, Busquets J, Secanella L, Peláez N, Serrano T, Fabregat J. [Duodenal adenocarcinoma: surgical results of 27 patients treated at a single center]. Adenocarcinoma duodenal: resultados del tratamiento quirúrgico de una serie unicéntrica de 27 pacientes. Cir Esp. 2019;97(9):523–530.
   PubMedGoogle Scholar
• Kim MJ, Choi SB, Han HJ, et al. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma. Kaohsiung J Med Sci. 2014;30(5):254–259.
   PubMed Web of Science ®Google Scholar
• Teufel A, Meindl-Beinker NM, Hösel P, et al. Characteristics and outcome of patients with small bowel adenocarcinoma (SBA). J Cancer Res Clin Oncol. 2023;149(8):4579–4590. doi:10.1007/s00432-022-04344-z
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lei Y, Wang D, Yang L, Lou C. Case Report: a case of advanced duodenal adenocarcinoma in complete remission after chemotherapy combined with targeted therapy and radiotherapy. Front Oncol. 2022;12:968110. doi:10.3389/fonc.2022.968110
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhong F. Comparative analysis of outcomes and clinicopathological characteristics of duodenal adenocarcinoma: a SEER analysis. Cancer Invest. 2020;38(10):543–548. doi:10.1080/07357907.2020.1824260
   PubMed Web of Science ®Google Scholar
• Gibbs JF. Duodenal adenocarcinoma: is total lymph node sampling predictive of outcome?. Ann Surg Oncol. 2004;11(4):354–355. doi:10.1245/ASO.2004.02.914
   PubMed Web of Science ®Google Scholar
• Ecker BL, McMillan MT, Datta J, et al. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: a matched cohort study. Eur J Cancer. 2016;69:135–141.
   PubMed Web of Science ®Google Scholar
• Mann K, Gilbert T, Cicconi S, et al. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma.. Langenbecks Arch Surg. 2019;404(4):439–449. doi:10.1007/s00423-019-01779-w
   PubMed Web of Science ®Google Scholar
• Jiang QL, Huang XH, Chen YT, Zhang JW, Wang CF. Prognostic factors and clinical characteristics of patients with primary duodenal adenocarcinoma: a single-center experience from China. Biomed Res Int. 2016;2016:6491049. doi:10.1155/2016/6491049
   PubMed Web of Science ®Google Scholar
• Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) Program. Oncologist. 2007;12(1):20–37. doi:10.1634/theoncologist.12-1-20
   PubMed Web of Science ®Google Scholar
• Ryder NM, Ko CY, Hines OJ, Gloor B, Reber HA. Primary duodenal adenocarcinoma: a 40-year experience. Arch Surg. 2000;135(9):1070–1075. doi:10.1001/archsurg.135.9.1070
   PubMedGoogle Scholar
• Hurtuk MG, Devata S, Brown KM, et al. Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection?. Am J Surg. 2007;193(3):319–325. doi:10.1016/j.amjsurg.2006.09.013
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zhou X, Zhang J, et al. Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study. Int J Clin Oncol. 2021;26(2):387–398.
   PubMed Web of Science ®Google Scholar
• Duhan S, Keisham B, Duhan C, Singh S, Jain A. Duodenal adenocarcinoma with suspected brain metastasis. Cureus. 2023;15(4):e38199. doi:10.7759/cureus.38199
   PubMed Web of Science ®Google Scholar
• Ecker BL, McMillan MT, Datta J, et al. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: a propensity score-matched analysis of a nationwide clinical oncology database. Cancer. 2017;123(6):967–976. doi:10.1002/cncr.30439
   PubMed Web of Science ®Google Scholar
• Lim YJ, Kim K. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, epidemiology, and end results database. Int J Clin Oncol. 2018;23(3):473–481. doi:10.1007/s10147-017-1226-7
   PubMed Web of Science ®Google Scholar
• Kaslow SR, Prendergast K, Vitiello GA, et al. Systemic therapy for duodenal adenocarcinoma: an analysis of the national cancer database (NCDB). Surgery. 2022;172(1):358–364. doi:10.1016/j.surg.2022.03.009
   PubMed Web of Science ®Google Scholar
• de Bakker JK, Meijer LL, Zonderhuis BM, van der Vliet HJ, Daams F, van Grieken NCT. Adjuvant chemotherapy for resected duodenal adenocarcinoma: a case-matched analysis in nation wide cohort. Acta Chir Belg. 2022;2022:1–7.
   Google Scholar
• Sakae H, Kanzaki H, Nasu J, et al. The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study. Br J Cancer. 2017;117(11):1607–1613. doi:10.1038/bjc.2017.338
   PubMed Web of Science ®Google Scholar
• Liu T, Wu Y, Jiang T. Efficacy of surgery and chemotherapy for stage IV small bowel adenocarcinoma: a population-based analysis using Surveillance, epidemiology, and end result program database. Cancer Med. 2020;9(18):6638–6645.
   PubMed Web of Science ®Google Scholar
• Hagihara S, Shimizu T, Inoue Y, et al. A complete response to capecitabine and oxaliplatin chemotherapy in primary duodenal carcinoma with liver and nodal metastases: a case report. Surg Case Rep. 2018;4(1):125. doi:10.1186/s40792-018-0532-2
   PubMedGoogle Scholar